# Cannabis use in chronic pancreatitis: A narrative review. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-use-chronic-pancreatitis-review/ > **Published:** 2026-03-26T00:07:13-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:38:58-04:00 > **Clinical Summary:** Explore cannabis use chronic pancreatitis and its potential role in pain management and opioid reduction in this narrative review. --- CED Clinical Relevance  #99High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. 🔬 Evidence Watch  |  CED Clinic [Chronic Pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/)PancreatitisOpioid-SparingThcPain Management Journal Pancreatology: official journal of the International Association of Pancreatology (IAP) … [et al.] Study Type Randomized Trial Population Human participants Why This Matters Chronic pancreatitis pain is notoriously difficult to treat, often requiring high-dose opioids with limited efficacy and significant addiction risk. This review examines cannabis as a potential adjunctive therapy for a condition where conventional pain management frequently fails. Clinical Summary This narrative review synthesized limited, mostly low-quality evidence on [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in chronic pancreatitis patients. [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was more common in younger male patients with chronic abdominal pain who were already on chronic opioids. One retrospective study suggested cannabis reduced daily opioid requirements, while a randomized controlled trial found THC did not significantly reduce abdominal pain. Several very low-quality studies reported improved outcomes in hospitalized patients using cannabis, but the overall evidence base remains insufficient for clinical recommendations. Dr. Caplan’s Take “I see this pattern repeatedly in pain medicine – patients are already using cannabis for conditions like chronic pancreatitis because conventional treatments aren’t working well enough. The opioid-sparing potential is encouraging, but we need much better studies before we can make evidence-based recommendations for this devastating condition.” Clinical Perspective 🧠 Clinicians should acknowledge that some chronic pancreatitis patients may already be using [cannabis for pain management](https://cedclinic.com/medical-cannabis-patient-benefits/) and should discuss this openly as part of comprehensive pain assessment. Until higher-quality studies emerge, any cannabis use should be carefully monitored alongside existing treatments, with particular attention to potential interactions with opioids and other medications. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Cannabis%20use%20in%20chronic%20pancreatitis%3A%20A%20narrative%20review.%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41455616/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41455616/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Cannabis%20use%20in%20chronic%20pancreatitis%3A%20A%20narrative%20review.%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41455616/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41455616/](https://pubmed.ncbi.nlm.nih.gov/41455616/) Table of Contents - [FAQ](#FAQ)[Is medical cannabis effective for treating chronic pancreatitis pain?](#Is_medical_cannabis_effective_for_treating_chronic_pancreatitis_pain) - [Which chronic pancreatitis patients are most likely to use cannabis?](#Which_chronic_pancreatitis_patients_are_most_likely_to_use_cannabis) - [Can medical cannabis help reduce opioid requirements in chronic pancreatitis?](#Can_medical_cannabis_help_reduce_opioid_requirements_in_chronic_pancreatitis) - [What does the research show about cannabis use in hospitalized chronic pancreatitis patients?](#What_does_the_research_show_about_cannabis_use_in_hospitalized_chronic_pancreatitis_patients) - [Should I recommend medical cannabis to my chronic pancreatitis patients?](#Should_I_recommend_medical_cannabis_to_my_chronic_pancreatitis_patients) - [Related](#Related) ## FAQ #### Is medical cannabis effective for treating chronic pancreatitis pain? Current evidence is limited and mostly low-quality. While one retrospective study showed decreased daily opioid use with [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/), a randomized controlled trial found that THC did not significantly reduce abdominal pain in chronic pancreatitis patients. #### Which chronic pancreatitis patients are most likely to use cannabis? Cannabis use is more prevalent among younger, male patients with chronic pancreatitis who have chronic abdominal pain and are taking opioids chronically. These demographic and clinical factors appear to predict higher rates of cannabis use in this population. #### Can medical cannabis help reduce opioid requirements in chronic pancreatitis? One retrospective study suggested that [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) was associated with decreased mean daily opioid use in chronic pancreatitis patients. However, this finding needs validation through higher-quality randomized controlled trials before making clinical recommendations. #### What does the research show about cannabis use in hospitalized chronic pancreatitis patients? Several very low-quality studies reported improved outcomes in hospitalized chronic pancreatitis patients who used cannabis. However, due to the poor quality of this evidence, these findings should be interpreted with significant caution. #### Should I recommend medical cannabis to my chronic pancreatitis patients? The existing evidence is insufficient to make definitive clinical recommendations about medical cannabis for chronic pancreatitis. Further high-quality research is needed to determine whether medical cannabis represents an effective therapy for these patients. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Cannabis use in chronic pancreatitis: A narrative review.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41455616/”, “about”: “pancreatology official journal international association pancreatology”, “isPartOf”: “Pancreatology: official journal of the International Association of Pancreatology (IAP) … [et al.]”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Some Cannabinoids May Ease Common Chronic Pain Conditions, Study Finds](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) This study explores how certain cannabinoids may provide relief for various [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) conditions, offering insights relevant to chronic pancreatitis pain management. [Read Study](https://cedclinic.com/some-cannabinoids-may-ease-common-chronic-pain-conditions-study-finds/) [Opioids and Cannabis: An Uncertain Combination?](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) An analysis of the complex relationship between opioid use and cannabis, highlighting considerations important for chronic pancreatitis patients using both. [Learn More](https://cedclinic.com/opioid-cannabis-interactions-risks-clinical-insights/) [New Study Suggests Cannabinoids May Offer Relief for Chronic Pain Conditions Including …](https://cedclinic.com/new-study-suggests-cannabinoids-may-offer-relief-for-chronic-pain-conditions-including/) This new research suggests cannabinoids could be beneficial for [chronic pain relief](https://cedclinic.com/former-nfl-quarterback-urges-athletes-to-consider-cbd-products/), providing context for their potential use in chronic pancreatitis. [Explore Findings](https://cedclinic.com/new-study-suggests-cannabinoids-may-offer-relief-for-chronic-pain-conditions-including/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).